Literature DB >> 18628304

An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells.

Hongbo Wang1, Daqian Sun, Peng Ji, James Mohler, Liang Zhu.   

Abstract

Androgen-androgen-receptor (androgen-AR) signaling in normal prostate epithelium promotes terminal luminal epithelial cell differentiation. In androgen-dependent prostate-cancer cells, androgen-AR signaling gains the ability to promote both differentiation and proliferation. How this signaling promotes proliferation of androgen-dependent prostate-cancer cells and its relationship with the differentiation-promoting functions of the AR are important issues regarding the biology of androgen-dependent prostate-cancer cells. Herein, we report the identification of an AR-Skp2 pathway in prostate-cancer cells that depend on the AR for proliferation; in this pathway, AR is a robust upstream regulator of Skp2 through blocking the D-box-dependent degradation of this protein, and Skp2, in turn, serves as an essential downstream effector of AR in promoting proliferation independently of the differentiation-promoting function of AR. These results provide new knowledge on how AR functions in androgen-dependent prostate-cancer cells and identify strategies to specifically target the proliferation-promoting function of AR without compromising cancer-cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628304      PMCID: PMC2729111          DOI: 10.1242/jcs.030742

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  61 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.

Authors:  Scott A Tomlins; Bharathi Laxman; Saravana M Dhanasekaran; Beth E Helgeson; Xuhong Cao; David S Morris; Anjana Menon; Xiaojun Jing; Qi Cao; Bo Han; Jindan Yu; Lei Wang; James E Montie; Mark A Rubin; Kenneth J Pienta; Diane Roulston; Rajal B Shah; Sooryanarayana Varambally; Rohit Mehra; Arul M Chinnaiyan
Journal:  Nature       Date:  2007-08-02       Impact factor: 49.962

3.  Skp2 contains a novel cyclin A binding domain that directly protects cyclin A from inhibition by p27Kip1.

Authors:  Peng Ji; Luba Goldin; Hao Ren; Daqian Sun; Daniele Guardavaccaro; Michele Pagano; Liang Zhu
Journal:  J Biol Chem       Date:  2006-06-14       Impact factor: 5.157

4.  Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.

Authors:  J Tsihlias; W Zhang; N Bhattacharya; M Flanagan; L Klotz; J Slingerland
Journal:  Oncogene       Date:  2000-02-03       Impact factor: 9.867

5.  Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice.

Authors:  A A Donjacour; G R Cunha
Journal:  Endocrinology       Date:  1993-06       Impact factor: 4.736

6.  p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase.

Authors:  H Zhang; R Kobayashi; K Galaktionov; D Beach
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

7.  Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.

Authors:  H C Wu; J T Hsieh; M E Gleave; N M Brown; S Pathak; L W Chung
Journal:  Int J Cancer       Date:  1994-05-01       Impact factor: 7.396

8.  Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

Authors:  Z Culig; A Hobisch; M V Cronauer; C Radmayr; J Trapman; A Hittmair; G Bartsch; H Klocker
Journal:  Cancer Res       Date:  1994-10-15       Impact factor: 12.701

9.  New androgen receptor genomic targets show an interaction with the ETS1 transcription factor.

Authors:  Charles E Massie; Boris Adryan; Nuno L Barbosa-Morais; Andy G Lynch; Maxine G Tran; David E Neal; Ian G Mills
Journal:  EMBO Rep       Date:  2007-08-17       Impact factor: 8.807

10.  A Skp2 autoinduction loop and restriction point control.

Authors:  Yuval Yung; Janice L Walker; James M Roberts; Richard K Assoian
Journal:  J Cell Biol       Date:  2007-08-27       Impact factor: 10.539

View more
  17 in total

1.  Androgens repress expression of the F-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells.

Authors:  Jingting Jiang; Yunqian Pan; Kevin M Regan; Changping Wu; Xueguang Zhang; Donald J Tindall; Haojie Huang
Journal:  Prostate       Date:  2011-05-31       Impact factor: 4.104

2.  Estimation of High-Dimensional Graphical Models Using Regularized Score Matching.

Authors:  Lina Lin; Mathias Drton; Ali Shojaie
Journal:  Electron J Stat       Date:  2016-04-06       Impact factor: 1.125

3.  Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2.

Authors:  Zuzana Pernicová; Eva Slabáková; Gvantsa Kharaishvili; Jan Bouchal; Milan Král; Zuzana Kunická; Miroslav Machala; Alois Kozubík; Karel Souček
Journal:  Neoplasia       Date:  2011-06       Impact factor: 5.715

4.  Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation.

Authors:  Wenwen Zhang; Lulu Cao; Zijia Sun; Jing Xu; Lin Tang; Weiwei Chen; Jiayan Luo; Fang Yang; Yucai Wang; Xiaoxiang Guan
Journal:  Cell Cycle       Date:  2016-04-25       Impact factor: 4.534

Review 5.  Skp2: a novel potential therapeutic target for prostate cancer.

Authors:  Zhiwei Wang; Daming Gao; Hidefumi Fukushima; Hiroyuki Inuzuka; Pengda Liu; Lixin Wan; Fazlul H Sarkar; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2011-09-22

6.  Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors.

Authors:  Christiane M Robbins; Waibov A Tembe; Angela Baker; Shripad Sinari; Tracy Y Moses; Stephen Beckstrom-Sternberg; James Beckstrom-Sternberg; Michael Barrett; James Long; Arul Chinnaiyan; James Lowey; Edward Suh; John V Pearson; David W Craig; David B Agus; Kenneth J Pienta; John D Carpten
Journal:  Genome Res       Date:  2010-12-08       Impact factor: 9.043

Review 7.  Functional roles of E3 ubiquitin ligases in prostate cancer.

Authors:  Yiting Zhao; Jinyun Li; Jun Chen; Meng Ye; Xiaofeng Jin
Journal:  J Mol Med (Berl)       Date:  2022-07-11       Impact factor: 5.606

8.  Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.

Authors:  Bo Li; Wenfu Lu; Qing Yang; Xiuping Yu; Robert J Matusik; Zhenbang Chen
Journal:  Prostate       Date:  2013-12-17       Impact factor: 4.104

9.  BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1.

Authors:  Wenwen Zhang; Jiayan Luo; Fang Yang; Yucai Wang; Yongmei Yin; Anders Strom; Jan Åke Gustafsson; Xiaoxiang Guan
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

10.  Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.

Authors:  Shuo Wei; Po-Chen Chu; Hsiao-Ching Chuang; Wen-Chun Hung; Samuel K Kulp; Ching-Shih Chen
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.